Glenmark Q1 net up 23 pct on US generics push; beats f'cast

MUMBAI Tue Jul 26, 2011 2:56pm IST

Related Topics

MUMBAI (Reuters) - Drugmaker Glenmark Pharmaceuticals' first quarter consolidated net profit rose 23 percent, substantially beating street estimates, as robust demand in the U.S. generics business pushed sales.

The Mumbai-based company on Tuesday reported a consolidated June quarter net profit of 2.10 billion rupees on net sales of 8.68 billion rupees.

A Reuters poll of 17 brokerages had forecast a net profit of 1.63 billion rupees on net sales of 7.93 billion rupees.

During the June quarter, Glenmark's U.S. generics business grew 37 percent to 2.81 billion rupees while sales from the European Union region more than doubled to 175.36 million rupees on year, the company said in a statement.

Domestic formulations revenue stood at 2.25 billion rupees in April-June, up 20 percent on year, it said.

"The India, U.S. and Latam (Latin America) business recorded strong growth for the quarter aided primarily by new products launched in the previous year," Glenn Saldanha, chairman and managing director, Glenmark Pharma, said in a statement.

"...Our drug discovery programme has also gained significant momentum during the quarter and we continue to remain confident of taking at least one new molecule to the clinics (human trials) every year."

Glenmark, in May, out-licensed its monoclonal antibody GBR500 to French drugmaker Sanofi for $613 million.

It also settled a litigation with Daiichi Sankyo Co Ltd and Genzyme Corp over colesevelam hydrochloride - a drug used to remove bile acids from the body.

At 2:13 p.m., shares of Glenmark Pharmaceuticals, which have gained 11.82 percent in value during April-June as compared to BSE healthcare index that rose 6.21 percent, were trading at 336.35 rupees, up 2.25 percent in a weak Mumbai market.

(Reporting by Kaustubh Kulkarni; Editing by Sunil Nair)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

WTO

REUTERS SHOWCASE

Factory Activity

Factory Activity

Factories post fastest growth for 17 months in July  Full Article 

Car Launch Ahead

Car Launch Ahead

Tata Motors bets on new sedan to revive weak India sales.  Full Article 

Gold Smuggling

Gold Smuggling

In cat-and-mouse game, India uncovers new gold smuggling route.  Full Article 

Market Eye

Market Eye

FII selling of Indian stocks on Thursday biggest in a month  Full Article 

Profit Falls

Profit Falls

DLF quarterly profit falls 29 pct on lower home sales  Full Article 

Re-gaining Momentum

Re-gaining Momentum

China PMIs jump to multi-month highs in July, add to view economy is steadying  Full Article 

Coal India

Coal India

Some Coal India mines may be run by foreign firms - minister  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage